TriSalus Life Sciences (TLSI) Operating Leases (2022 - 2026)

TriSalus Life Sciences (TLSI) has 5 years of Operating Leases data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 8.39% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 8.39% YoY), and the FY2025 full-year result was $1.2 million, down 7.6% from the prior year.
• Operating Leases for Q1 2026 stood at $1.2 million, down from $1.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $1.6 million in Q4 2022 and bottomed at $1.2 million in Q2 2024.
• The 5-year median for Operating Leases is $1.3 million (2023), against an average of $1.3 million.
• The widest annual swing landed in 2023, when Operating Leases dropped 21.91%; it then increased 14.26% in 2024.
• A 5-year view of Operating Leases shows it stood at $1.6 million in 2022, then fell by 21.91% to $1.2 million in 2023, then gained by 6.83% to $1.3 million in 2024, then declined by 7.6% to $1.2 million in 2025, then dropped by 3.09% to $1.2 million in 2026.
• The last three Operating Leases figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison